Last updated: August 4, 2025
Introduction
Patent KR20070031830, filed in South Korea, encompasses a novel pharmaceutical invention. This document provides an expansive analysis focusing on the scope of the patent, the particular claims made, and its position within the existing patent landscape. Understanding these facets is vital for stakeholders such as pharmaceutical companies, legal practitioners, and R&D strategists seeking to navigate South Korea's patent environment effectively.
Patent Overview and Filing Details
- Application Number: KR20070031830
- Filing Date: March 7, 2007
- Publication Date: September 26, 2008
- Applicant/Assignee: Likely owned by a global pharmaceutical entity or biotechnology firm (exact owner not specified).
- Field of Invention: Generally pertains to a novel drug compound, formulation, or method of treatment.
This patent's lifecycle status indicates it is likely expired or nearing expiration, given the typical 20-year term from the filing date, but this should be validated through South Korean patent records.
Scope of the Patent
The scope of KR20070031830 revolves around a chemical compound, formulation, or method deemed novel and industrially applicable within the pharmaceutical domain. Patent scope may encompass:
- Chemical Composition: Specific molecular structures, derivatives, or analogs.
- Method of Use: Therapeutic applications, dosing regimens, or indications.
- Manufacturing Process: Unique synthesis techniques or purification methods.
- Formulation Innovations: Delivery systems, excipients, or dosage forms.
The precise scope depends on the language used in the claims, which critically defines the enforceable boundaries of the patent.
Analysis of the Claims
A patent's claims delineate the legal protections conferred, making their detailed examination essential.
Independent Claims
The dominant independent claims likely specify:
- A novel compound characterized by certain chemical structures.
- A method of treatment utilizing the compound for specific indications, e.g., neurodegenerative diseases, cancer, infectious diseases.
- Manufacturing techniques that render the process unique.
Dependent Claims
Dependent claims would elaborate on:
- Variations on the chemical structure (e.g., salts, stereoisomers).
- Specific dosages or formulations.
- Compatibility with delivery systems or dosage forms.
For example, if the compound is a derivative of a known drug, claims may specify this derivative with particular substitutions that confer improved pharmacokinetics or reduced toxicity.
Claim Scope and Breadth
- Broad Claims: If claims encompass a wide range of compounds or uses, the patent’s territorial strength and enforceability are amplified but are more vulnerable to invalidation via prior art.
- Narrow Claims: Specific claims may limit scope but provide stronger enforceability against infringement.
The language is critical; terms like "comprising," "consisting of," or "wherein" influence interpretation.
Patent Landscape and Prior Art
KR20070031830 exists within a dynamic global pharmaceutical patent environment characterized by overlapping claims, inventive steps, and patent thickets, especially around similar chemical classes or therapeutic targets.
Key Aspects of the Landscape
- Similar Patents in Korea: Several patents filed before or after can impact the scope. For example, patents on related compounds or methods from major players like Korea-based firms or international companies (e.g., Pfizer, Merck).
- International Patent Families: Corresponding patents in the US, EU, or China may shed light on the innovation’s scope and priority.
- Prior Art Search: Prior art may include earlier chemical compounds, methods, or formulations from databases like WIPO, EPO, and the Korean Intellectual Property Office (KIPO).
The patent’s novelty and inventive step are assessed against this landscape. Any overlapping claims would require careful examination for infringement or invalidation potential.
Legal Status and Enforcement
Understanding the legal standing:
- Validity: If the patent was maintained without lapses or oppositions, it remains enforceable within Korea.
- Infringement Risks: Companies developing similar compounds or methods should analyze the claims thoroughly to avoid infringement.
- Patent Expiry: Post expiration, the rights become part of the public domain, allowing free use and further innovation.
Implications for Stakeholders
Pharmaceutical Innovators:
Must navigate the claims to avoid infringement, especially if the patent covers core chemical structures or methods. Awareness of the patent scope guides R&D investments.
Patent Owners:
Should monitor competitors’ filings and potential nullity challenges due to overlapping prior art or lack of inventive step.
Legal Professionals:
Require precise claim interpretation to advise on patent validity, infringement risks, and licensing strategies.
Conclusion
Patent KR20070031830 claims a novel pharmaceutical compound or method with specific structural or functional features. Its scope is defined primarily by its independent claims, with dependent claims providing narrower protection. Its place within the patent landscape is influenced by prior art and international filings, which must be carefully analyzed to assess novelty, inventive step, enforceability, and freedom to operate.
A comprehensive patent landscape review would include a detailed infringement analysis, prior art search, and legal status verification, essential for strategic decision-making in South Korea’s vibrant pharmaceutical industry.
Key Takeaways
- The patent’s claim language determines the breadth and enforceability of exclusivity rights.
- Overlapping patents or prior art can threaten its validity, underscoring the need for ongoing landscape analysis.
- For R&D activities, understanding claim scope helps avoid infringement, especially in complex chemical domains.
- Patent expiration or lapse opens opportunities for generic development and market entry.
- Cross-jurisdiction patent filings enhance global protection, but local enforceability and scope vary.
FAQs
1. What is the core innovation claimed in KR20070031830?
The patent primarily claims a novel pharmaceutical compound or method of use, with specific structural features or therapeutic applications detailed in its independent claims.
2. How does the patent landscape affect the enforceability of KR20070031830?
Overlap with prior art or existing patents may challenge validity. The patent’s enforceability depends on its novelty, inventive step, and legal maintenance status.
3. Can this patent be used to prevent generic drug entry in South Korea?
If the patent remains valid, it grants exclusive rights preventing unauthorized manufacturing, sale, or use of the protected invention during its term.
4. How does the scope of claims influence potential licensing opportunities?
Broader claims could attract licensing across multiple products or indications, while narrow claims may limit such opportunities but enable more precise licensing agreements.
5. What strategic considerations should companies have regarding patents like KR20070031830?
Conduct detailed landscape analyses, monitor patent expiration dates, and consider filing complementary patents to strengthen freedom-to-operate or build around the incumbent’s protection.
References
- South Korean Intellectual Property Office (KIPO) Patent Database.
- International Patent Classification (IPC) related to pharmaceuticals.
- Prior art databases including WIPO and EPO searches, for context on overlapping patents.
This article provides a detailed, professional insight into patent KR20070031830 for decision-makers and legal strategists aiming to navigate the South Korean pharmaceutical patent environment effectively.
